摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3α-acetoxy-34-nor-5βH-cholane-23-carboxyl)-2-pyridinethione | 173776-80-2

中文名称
——
中文别名
——
英文名称
N-(3α-acetoxy-34-nor-5βH-cholane-23-carboxyl)-2-pyridinethione
英文别名
(2-sulfanylidenepyridin-1-yl) (4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-acetyloxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate
N-(3α-acetoxy-34-nor-5βH-cholane-23-carboxyl)-2-pyridinethione化学式
CAS
173776-80-2
化学式
C31H45NO4S
mdl
——
分子量
527.769
InChiKey
SRPWBVLPYUHGMV-HGONFWIOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.1
  • 重原子数:
    37
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.77
  • 拓扑面积:
    87.9
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    N-(3α-acetoxy-34-nor-5βH-cholane-23-carboxyl)-2-pyridinethione 在 titanium(III) chloride 、 camphor-10-sulfonic acid 作用下, 以 四氢呋喃乙醚 为溶剂, 反应 20.25h, 生成 5β-cholestane-3α,25-diol
    参考文献:
    名称:
    Barton, Derek H. R.; Boivin, Jean; Lelandais, Patrick, Journal of the Chemical Society. Perkin transactions I, 1989, p. 463 - 468
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    通过巴顿自由基脱羧和苯醌加成从胆汁酸合成甾体醌和氢醌。研究它们的细胞毒性和抗真菌活性
    摘要:
    通过巴顿脱羧反应制备了 12 种新的氢醌和醌(4a-c 至 7a-c)(4a-c 至 7a-c),这些化合物来自游离或过乙酰化胆汁酸,随后被苯醌捕获。所有新化合物均通过 2D NMR 技术完全表征,并筛选了抗真菌和细胞毒活性。其中一种新的氢醌 (7b) 对人胰腺导管癌细胞系 PANC1 显示出有希望的结果,具有与商业化疗药物阿霉素相似的细胞毒活性。
    DOI:
    10.1016/j.steroids.2011.09.012
点击查看最新优质反应信息

文献信息

  • The reaction of thionitrites with barton esters: a convenient free radical chain reaction for decarboxylative nitrosation
    作者:Pierre Girard、Nadine Guillot、William B. Motherwell、Robyn S. Hay-Motherwell、Pierre Potier
    DOI:10.1016/s0040-4020(98)01164-8
    日期:1999.3
    Tertiary thionitrite esters react with primary and secondary O-acyl derivatives of N-hydroxy-2-thiopyridone to give trans nitroso dimers as the principal products of a free radical chain reaction.
    亚硝酸酯与N-羟基-2-吡啶酮的伯和仲O-酰基衍生物反应,生成反式亚硝基二聚体,作为自由基链反应的主要产物。
  • Antiparasitic hybrids of Cinchona alkaloids and bile acids
    作者:Aurélie Leverrier、Joanne Bero、Michel Frédérich、Joëlle Quetin-Leclercq、Jorge Palermo
    DOI:10.1016/j.ejmech.2013.06.004
    日期:2013.8
    A series of 16 hybrids of Cinchona alkaloids and bile acids (4a-h, 5a-h) was prepared by means of a Barton-Zard decarboxylation reaction. Quinine, quinidine, cinchonine and cinchonidine were functionalized at position C-2 of the quinoline nucleus by radical attack of a norcholane substituent. The newly synthesized hybrids were evaluated in vitro for their antitrypanosomal, antileishmanial and antiplasmodial activities, along with their cytotoxicity against WI38, a normal human fibroblast cell line. Seven compounds (4d, 4f, 4h, 5b, 5d, 5f, 5h) showed promising trypanocidal activity with IC50 values in the same range as the commercial drug suramine. Moreover all the 16 hybrids showed antiplasmodial activity (IC50 <= 6 mu g/ml), particularly those containing a nor-chenodeoxycholane moiety (4b, 4d, 4f, 4h, 5b, 5d, 5f, 5h) with IC50 values comparable to those of the natural alkaloids, and selectivity indices in the range of 5.6-15.7. (C) 2013 Elsevier Masson SAS. All rights reserved.
  • ——
    作者:Carl H. Schiesser、Melissa A. Skidmore、Jonathan M. White
    DOI:10.1071/ch01045
    日期:——
    7 alpha-(Dimethylstannyl)-24-nor-5 beta -cholane (12) and 3 beta-(dimethylstannyl)-24-nor-5 beta -cholane (11) have been prepared from cholic and lithocholic acid, respectively, as free-radical reducing agents. Limited enantioselectivity-testing data indicate that these compounds show promise as enantioselective free-radical reducing agents. For example, reaction of ethyl (rac)-2-bromo-2-cyclopentyl-2-phenylacetate with one equivalent of either (11) or (12) in the presence of one equivalent of (S,S)-(-)-N,N'-bis(3,5-di-tert-butylsalycidene)-1,2-cyclohexanediaminomanganese(III) chloride (7) in toluene at -78 degreesC provides ethyl (S)-2-cyclopentyl-2-phenylacetate, obtained with 62 and 90% ee, respectively.
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B